FUSION PHARMACEUTICALS INC - COM (FUSN)

CUSIP: 36118A100

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
26,582,690
Share change
-1,277,361
Total reported value
$80,314,943
Price per share
$3.01
Number of holders
31
Value change
-$2,694,667
Number of buys
13
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FUSION PHARMACEUTICALS INC - COM (FUSN) as of Q3 2022

As of 30 Sep 2022, FUSION PHARMACEUTICALS INC - COM (FUSN) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,582,690 shares. The largest 10 holders included JOHNSON & JOHNSON, ORBIMED ADVISORS LLC, FEDERATED HERMES, INC., CANADA PENSION PLAN INVESTMENT BOARD, FMR LLC, ADAMS STREET PARTNERS LLC, TPG GP A, LLC, Pivotal bioVenture Partners Investment Advisor LLC, Artal Group S.A., and 1832 Asset Management L.P.. This page lists 31 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.